Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.

מידע ביבליוגרפי
Main Authors: V. M. Alifirova, M. A. Titova, A. A. Vereschaka
פורמט: Article
שפה:English
יצא לאור: Siberian State Medical University (Tomsk) 2010-08-01
סדרה:Бюллетень сибирской медицины
נושאים:
גישה מקוונת:https://bulletin.ssmu.ru/jour/article/view/1618

פריטים דומים